Document Detail


The burden of ischemic heart disease at a major cardiac center in Central Saudi Arabia.
MedLine Citation:
PMID:  22159384     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
OBJECTIVE: To estimate the direct medical costs associated with ischemic heart disease (IHD) at Prince Sultan Cardiac Center (PSCC) in Riyadh, Saudi Arabia.
METHODS: This is a prevalence-based prospective observational cost of illness study conducted in PSCC, Riyadh, Kingdom of Saudi Arabia between April and June 2009. All patients diagnosed or suspected of having IHD at admission were included. They were followed up until discharge, or performing coronary artery bypass graft (CABG), or changing diagnosis. Clinical data were extracted from the patients' computerized database, and combined with the unit cost of services to calculate costs.
RESULTS: A total of 205 patients were recruited and diagnosed with stable angina (SA, 47.8%), unstable angina (USA, 24.4%), ST-segment elevation myocardial infarction (STEMI, 19.5%), and non-ST-segment elevation myocardial infarction (NSTEMI, 8.3%). Most of the patients were Saudi males, aged between 40-75 years. Eighty-seven percent of patients had 2 or more co-morbidities, and 32% of the patients were obese. The average cost was 40,164 Saudi Riyals (SAR)/patient (US$10,710). Medication contributed the lowest in the costs (3.2%). A cost associated with SA was SAR33,991, USA was SAR35,107, NSTEMI was SAR46,585, and STEMI was SAR58,877 per patient. The lowest mean hospital length of stay was 6.5 days with SA. The average length of stay increased with the number of co-morbidities from 5.67 days (no co-morbidity) to 11.25 days (6 co-morbidities).
CONCLUSION: The IHD is of high economic burden in the country. Among IHD types studied, the resource consumption associated to STEMI was the highest in terms of costs, and hospital length of stay.
Authors:
Ahmed M Osman; Mohammed S Alsultan; Meshal A Al-Mutairi
Related Documents :
22629034 - Inferior myocardial infarction secondary to aortic dissection associated with bicuspid ...
21130864 - In vivo hyperoxic preconditioning protects against rat-heart ischemia/reperfusion injur...
22354194 - First-in-man study of simvastatin-eluting stent in de novo coronary lesions: the simvas...
22425234 - Left ventricular dilation and functional impairment assessed by gated spect are indicat...
8017264 - Thrombosis and restenosis after stenting in failed angioplasty: comparison with electiv...
21321124 - Chronic inhibition of pyruvate dehydrogenase in heart triggers an adaptive metabolic re...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Saudi medical journal     Volume:  32     ISSN:  0379-5284     ISO Abbreviation:  Saudi Med J     Publication Date:  2011 Dec 
Date Detail:
Created Date:  2011-12-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7909441     Medline TA:  Saudi Med J     Country:  Saudi Arabia    
Other Details:
Languages:  eng     Pagination:  1279-83     Citation Subset:  IM    
Affiliation:
Pharmacoeconomics Research Unit, Clinical Pharmacy Department, College of Pharmacy, King Saud University, PO Box 2457, Riyadh 11451, Kingdom of Saudi Arabia. Tel. +966 507222277. Fax. +966 (1) 4450765. E-mail: amyn@ksu.edu.sa/ahmed.m.yehia@gmail.com.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Impact of tinnitus on the quality of life among Saudi patients.
Next Document:  Assessment of quality of life in patients with type 2 diabetes mellitus in Oman.